Rigel Reports First Quarter 2026 Financial Results
Go back to Rigel Reports First Quarter 2026 Financial Results| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 49.10 +0.38 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.72 | 52 Week High | $4.38 | |||
| Open | $48.60 | 52 Week Low | $1.88 | |||
| Day High | $50.49 | P/E | N/A | |||
| Day Low | $48.60 | EPS | $-1.12 | |||
| Volume | 75,031 | |||||



